6Zacharski LR, Prandoni P, Monreal M. Warfarin versus low - molecular- weight heparin therapy in cancer patients [J] . Oncologist, 2005, 10 (1): 72-79.
7Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP conference on antithromboric and thrombolytic therapy [ J ] . Chest, 2004, 126 (3Suppl) : 338 -400.
8Kher A, Samama MM. Prmary and secondary prophylaxis of venous thromboembolism with low - molecular - weight heparins, prolonged thromboprophy laxis, an alternative to vitamin Kantagonista [J] .Thromb Haemost, 2005, 3 (3): 473-481.
